Chronic ITP is a common hematologic illness. Approximately three fourths of the patients respond to corticosteroids or splenectomy and need no further treatment. Patients refractory to these two therapeutic approaches are relatively resistant to present forms of treatment and are at much greater risk for morbidity and mortality. Future clinical studies evaluating therapy in this refractory group would be best performed in a cooperative group setting in which large numbers of patients could be treated in a prospective randomized manner.
REVIEW ARTICLES| November 15, 1989
Therapy of chronic idiopathic thrombocytopenic purpura in adults [see comments]
Blood (1989) 74 (7): 2309-2317.
- Share Icon Share
- Tools Icon Tools
- Search Site
- PDF LinkPDF
P Berchtold, R McMillan; Therapy of chronic idiopathic thrombocytopenic purpura in adults [see comments]. Blood 1989; 74 (7): 2309–2317. doi: https://doi.org/10.1182/blood.V74.7.2309.bloodjournal7472309
Download citation file: